Oppositions filed to Cellegy hemorrhoid treatment patent in Europe.(Brief Article): An article from: BIOTECH Patent News
Oppositions filed to Cellegy hemorrhoid treatment patent in Europe.(Brief Article): An article from: BIOTECH Patent News
|
 List Price: $5.95 Sale Price: $5.95 Availability: Available for download now 
|
Product Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on June 1, 2001. The length of the article is 6329 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Oppositions filed to Cellegy hemorrhoid treatment patent in Europe.(Brief Article)
Publication: BIOTECH Patent News (Newsletter)
Date: June 1, 2001
Publisher: Biotech Patent News
Volume: 15 Issue: 6 Page: NA
Article Type: Brief Article
Distributed by Thomson Gale
Details
No features available.
Related Blogs
- Amazon.Com Inc. (AMZN) goes positive by breaking intraday moving …
- GM's latest shakeup reassigns product planning, development execs
- Digital Bids » Blog Archiv » AMZN Added To Goldman Conviction Buy …
- 10 Things You Need To Know This Morning (AAPL, AMZN, YHOO) « Apple …
- What is the Best Weight Loss Product Online? How to Choose the …
- Product containing ephedrine | Pharmacy
- Announcing the Product Strategy Workshop in Delhi [June 26th, 2010]
- Intraday Commentary ~ 6/04/2010 $AMZN, $SPY, … – FocalEquity
- Pre Market Alerts for June 7; TLCR, BPAX, ARQL, AAPL, AMZN …
- Top Pre-Market Upgrades/Downgrades (AMZN, ANN, BMY, CSCO, BP, AAPL …
- 30 Product Package Designs Showcasing Amazing High Quality Package …
- New Week, New Product « Alice.com Blog – Unique Finds & Practical …
- Top Analyst Upgrades and Downgrades (AMZN, ANN, ABT, ATHN, ADSK …
I’ve recently started a blog, the information you provide on this site has helped me tremendously. Thank you for all of your time & work.